358 related articles for article (PubMed ID: 33830145)
21. [ACE-inhibitors, angiotensin receptor blockers and severe acute respiratory syndrome caused by coronavirus].
Verdecchia P; Reboldi G; Cavallini C; Mazzotta G; Angeli F
G Ital Cardiol (Rome); 2020 May; 21(5):321-327. PubMed ID: 32310915
[TBL] [Abstract][Full Text] [Related]
22. Paediatric COVID-19 and the GUT.
Gupta R; Beg S; Jain A; Bhatnagar S
Indian J Med Microbiol; 2020; 38(3 & 4):261-264. PubMed ID: 33154233
[TBL] [Abstract][Full Text] [Related]
23. Potential pathogenesis of severe acute respiratory syndrome coronavirus 2.
Wu T; Zhang H; Hu E; Ma J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):591-597. PubMed ID: 32879112
[TBL] [Abstract][Full Text] [Related]
24. Gastrointestinal manifestations and nutritional therapy during COVID-19 pandemic: a practical guide for pediatricians.
Oba J; Carvalho WB; Silva CA; Delgado AF
Einstein (Sao Paulo); 2020; 18():eRW5774. PubMed ID: 32667418
[TBL] [Abstract][Full Text] [Related]
25. COVID-19, coronavirus, SARS-CoV-2 and the small bowel.
Mönkemüller K; Fry L; Rickes S
Rev Esp Enferm Dig; 2020 May; 112(5):383-388. PubMed ID: 32343593
[TBL] [Abstract][Full Text] [Related]
26. Histopathology and ultrastructural findings of fatal COVID-19 infections in Washington State: a case series.
Bradley BT; Maioli H; Johnston R; Chaudhry I; Fink SL; Xu H; Najafian B; Deutsch G; Lacy JM; Williams T; Yarid N; Marshall DA
Lancet; 2020 Aug; 396(10247):320-332. PubMed ID: 32682491
[TBL] [Abstract][Full Text] [Related]
27. Gastrointestinal and Hepatic Manifestations of COVID-19: Evolving Recognition and Need for Increased Understanding in Vulnerable Populations.
Garland V; Kumar AB; Borum ML
J Natl Med Assoc; 2021 Apr; 113(2):142-146. PubMed ID: 32807512
[TBL] [Abstract][Full Text] [Related]
28. Gastrointestinal, hepatic and pancreatic manifestations of COVID-19 in children.
Pegoraro F; Trapani S; Indolfi G
Clin Res Hepatol Gastroenterol; 2022 Apr; 46(4):101818. PubMed ID: 34607068
[TBL] [Abstract][Full Text] [Related]
29. Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein.
Johnson MC; Lyddon TD; Suarez R; Salcedo B; LePique M; Graham M; Ricana C; Robinson C; Ritter DG
J Virol; 2020 Oct; 94(21):. PubMed ID: 32788194
[TBL] [Abstract][Full Text] [Related]
30. Targeting Proteases for Treating COVID-19.
Luan B; Huynh T; Cheng X; Lan G; Wang HR
J Proteome Res; 2020 Nov; 19(11):4316-4326. PubMed ID: 33090793
[TBL] [Abstract][Full Text] [Related]
31. Temporal Correlation Between Neurological and Gastrointestinal Symptoms of SARS-CoV-2.
Bostancıklıoğlu M
Inflamm Bowel Dis; 2020 Jul; 26(8):e89-e91. PubMed ID: 32440692
[TBL] [Abstract][Full Text] [Related]
32. Gastrointestinal involvement of COVID-19 and potential faecal transmission of SARS-CoV-2.
Song M; Li ZL; Zhou YJ; Tian G; Ye T; Zeng ZR; Deng J; Wan H; Li Q; Liu JB
J Zhejiang Univ Sci B; 2020 Sept.; 21(9):749-751. PubMed ID: 32893532
[TBL] [Abstract][Full Text] [Related]
33. Critical appraisal of the mechanisms of gastrointestinal and hepatobiliary infection by COVID-19.
Levy E; Stintzi A; Cohen A; Desjardins Y; Marette A; Spahis S
Am J Physiol Gastrointest Liver Physiol; 2021 Aug; 321(2):G99-G112. PubMed ID: 34009033
[TBL] [Abstract][Full Text] [Related]
34. Gastrointestinal manifestations of coronavirus disease 2019.
Joshi T; Ahmed A; Cholankeril G
Curr Opin Infect Dis; 2021 Oct; 34(5):471-476. PubMed ID: 34524198
[TBL] [Abstract][Full Text] [Related]
35. Potential effects of SARS-CoV-2 on the gastrointestinal tract and liver.
Lei HY; Ding YH; Nie K; Dong YM; Xu JH; Yang ML; Liu MQ; Wei L; Nasser MI; Xu LY; Zhu P; Zhao MY
Biomed Pharmacother; 2021 Jan; 133():111064. PubMed ID: 33378966
[TBL] [Abstract][Full Text] [Related]
36. Gastrointestinal manifestations and possible mechanisms of COVID-19 in different periods.
Zhang MM; Chen LN; Qian JM
J Dig Dis; 2021 Dec; 22(12):683-694. PubMed ID: 34738727
[TBL] [Abstract][Full Text] [Related]
37. Paediatric gastrointestinal disorders in SARS-CoV-2 infection: Epidemiological and clinical implications.
Al-Beltagi M; Saeed NK; Bediwy AS; El-Sawaf Y
World J Gastroenterol; 2021 Apr; 27(16):1716-1727. PubMed ID: 33967552
[TBL] [Abstract][Full Text] [Related]
38. Gastrointestinal and hepatic involvement during COVID-19 pandemic: A focus on pediatric population and possible future implications.
Sica R; Pennoni S; Penta L; Riccioni S; Di Cara G; Verrotti A
World J Gastroenterol; 2021 Oct; 27(40):7000-7004. PubMed ID: 34790020
[TBL] [Abstract][Full Text] [Related]
39. COVID-19 and the liver: A 2021 update.
Spearman CW; Aghemo A; Valenti L; Sonderup MW
Liver Int; 2021 Sep; 41(9):1988-1998. PubMed ID: 34152690
[TBL] [Abstract][Full Text] [Related]
40. COVID-19 and the gastrointestinal tract: Source of infection or merely a target of the inflammatory process following SARS-CoV-2 infection?
Troisi J; Venutolo G; Pujolassos Tanyà M; Delli Carri M; Landolfi A; Fasano A
World J Gastroenterol; 2021 Apr; 27(14):1406-1418. PubMed ID: 33911464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
